Abstract
Lung cancer is one of the most common oncological diagnoses in the United States. When diagnosed at an early stage, surgical resection or occasionally stereotactic radiation can be curative. Localized lung cancers can be resected with lobectomy, pneumonectomy, or sleeve resection removing the tumor and bronchus. Almost 40% of patients are not surgical candidates due to comorbidities related to smoking. Lung cancer is frequently diagnosed in its later stages due to many overlapping symptoms from comorbid medical conditions such as tobacco abuse and chronic obstructive pulmonary disease (COPD). Common medical considerations associated with this diagnosis include supplemental oxygen, palliative radiation, and pain management to name a few. Patients who have been treated for lung cancer may present with a variety of impairments and frequently have limited exercise tolerance from dyspnea and pain. These patients can use exercise as well as physical, occupational, and speech therapies throughout the course of their disease to help reduce morbidity and improve their quality of life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 2007;25:5570–7.
Brunelli A, Kim AW, Berger KI, Adrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e166S–90S.
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy: a randomised clinical trial. Lancet Oncol. 2009;10:467–74.
Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265–71.
O’Brien ME, Ciuleanu TE, Tsekov H, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol. 2006;24:5441–7.
Kalemkerian GP, Akerley W, Bogner P, et al. Small cell lung cancer. J Natl Compr Cancer Netw. 2013;11:78–98.
Sterlacci W, Savic S, Schmid T, et al. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact. Am J Clin Pathol. 2012;137:946–56.
Paci M, Cavazza A, Annessi V, et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg. 2004;77:1163.
Predina JD, Kunkala M, Aliperti LA, Singhal AK, Singhal S. Sleeve lobectomy: current indications and future directions. Ann Thorac Cardiovasc Surg. 2010;16:310–8.
Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by LACE Collaborative Group. J Clin Oncol. 2008;26:3552–9.
Strauss GM, Wang XF, Maddaus M, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): long-term follow-up of Cancer and Leukemia Group B (CALGB) 9633. J Clin Oncol. 2011;29:7015.
Spiro SG, Rudd RM, Souhami RL, et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax. 2004;59:828–36.
Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006;355(24):2542–50.
Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973-2005. Crit Rev Toxicol. 2009;39(7):576–88.
Robinson B. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1(4):491–6.
Rusch VW, Giroux D, Kennedy C, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7(11):1631–9.
Adams RF, Gleeson FV. Percutaneous image-guided cutting-needle biopsy of the pleura in the presence of a suspected malignant effusion. Radiology. 2001;219(2):510–4.
Zhao S, Chen F, Wang D, et al. Effect of preoperative smoking cessation on postoperative pain outcomes in elderly patients with high nicotine dependence. Medicine (Baltimore). 2019;98(3):e14209. https://doi.org/10.1097/MD.0000000000014209.
Kendall F, Abreu P, Pinho J, et al. The role of physiotherapy in patients undergoing pulmonary surgery for lung cancer: a literature review. Rev Port Pneumol. 2017;23(6):343–51. https://doi.org/10.1016/j.rppnen/2017.05.003. Accessed 1/14/19.
Smith SR, Khanna A, Wisotzky EM. An evolving role for cancer rehabilitation in the era of low-dose lung computed tomography screening. PMR. 2017;9:S407–14.
Iyer S, Roughley A, Rider A, et al. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study. Support Care Cancer. 2014;22:181–7.
Chen J, Lu JJ, Ma N, et al. Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy. Radiat Oncol. 2019;14(1):16. https://doi.org/10.1186/s13014-019-1216-1.
New P. Radiation injury to the nervous system. Curr Opin Neurol. 2001;14:725–34.
Shulman RM, Meyer JE, Li T, Howell KJ. External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs). Ann Palliat Med. 2018. pii: apm.2018.10.04; https://doi.org/10.21037/apm.2018.10.04.
den Otter LA, Kaza E, Kierkels RGJ, et al. Reproducibility of the lung anatomy under active breathing coordinator control: dosimetric consequences for scanned proton treatment. Med Phys. 2018;45(12):5525–34.
Kaza E, Dunlop A, Panek R, et al. Lung volume reproducibility under ABC control and self-sustained breath holding. J Appl Clin Med Phys. 2017;18(2):154–62. https://doi.org/10.1002/acm2.12034.
Butts CA, Ding K, Seymour L, et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol. 2010;28(1):29–34.
Cheng X, Huo J, Wang D, et al. Herbal medicine AC591 prevents oxaliplatin-induced peripheral neuropathy in animal model and cancer patients. Front Pharmacol. 2017;8:344.
Garja A, Karim NA, Mulford D, et al. nab-Paclitaxel–based therapy in underserved patient populations: the ABOUND.PS2 study in patients with NSCLC and a performance status of 2. Front Oncol. 2018;8(253) https://doi.org/10.3389/fonc.2018.00253.
Fodeh SJ, Lazenby M, Bai M, et al. Functional impairments as symptoms in the symptom cluster analysis of patients newly diagnosed with advanced cancer. J Pain Symptom Manag. 2013;46(4):500–10. https://doi.org/10.1016/j.jpainsymman.2012.09.011.
Ostroff JS, Krebs P, Coups EJ, et al. Health-related quality of life among early-stage, non-small cell, lung cancer survivors. Lung Cancer. 2011;71(1):103–8. https://doi.org/10.1016/j.lungcan.2010.04.011.
Wiskermann J, Hummler S, Diepold C, et al. POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment. BMC Cancer. 2016;16:499.
American Cancer Society ACS Guidelines for Physical Activity and the Cancer Patient. [Accessed January 31, 2019]. Available from: https://www.cancer.org/treatment/survivorship-during-and-after-treatment/staying-active/physical-activity-and-the-cancer-patient.html.
Silver JK, Baima J, Mayer RS. Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship. CA Cancer J Clin. 2013;63(5):295–317.
Morano MT, Araujo AS, Nascimento FB, et al. Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial. Arch Phys Med Rehabil. 2013;94:53–8.
Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR, Joy AA, Kumar V, Winton TW, Reiman T. Cancer. 2007;110(3):590–8.
Divisi D, Di Francesco C, Di Leonardo G, Crisci R. Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease. Eur J Cardiothorac Surg. 2013;43:293–6.
Quist M, Rorth M, Langer S, et al. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer. 2012;75:203–8.
Zhang LL, Wang SZ, Chen HL, Yuan AZ. Tai Chi exercise for cancer-related fatigue in patients with lung cancer undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manag. 2016;51(3):504–11.
Cheville AL, Kollasch J, Vandenberg J, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manag. 2013;45(5):811–21.
Henshall CL, Allin L, Aveyard H. A systematic review and narrative synthesis to explore the effectiveness of exercise-based interventions in improving fatigue, dyspnea, and depression in lung cancer survivors. Cancer Nurs. 2018;42(4):295–306. https://doi.org/10.1097/NCC.0000000000000605.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mitchell, C., Raj, V., Pugh, T. (2020). Cancer of the Respiratory and Intrathoracic Organs. In: Baima, J., Khanna, A. (eds) Cancer Rehabilitation . Springer, Cham. https://doi.org/10.1007/978-3-030-44462-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-44462-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44461-7
Online ISBN: 978-3-030-44462-4
eBook Packages: MedicineMedicine (R0)